Abstract
Microtubule as an important target in the cancer therapy was used to design novel tubulin polymerization inhibitors. Sulfanilamide-1,2,3-triazole hybrids were designed by a molecular hybridization strategy and their antiproliferative activity against three selected cancer cell lines (BGC-823, MGC-803 and SGC-7901) were evaluated. All sulfanilamide-1,2,3-triazole hybrids displayed potent inhibitory activity against all cell lines. In particular, compound 10b showed the most excellent inhibitory effect against MGC-803 cells, with an IC50 value of 0.4 μM. Cellular mechanism studies elucidated that 10b induced apoptosis by decreasing the expression level of Bcl-2 and Parp and increasing the expression level of BAX. 10b inhibited the epithelial-mesenchymal transition process by up-regulating E-cadherin and down-regulating N-cadherin. Furthermore, the tubulin polymerization inhibitory activity in vitro of 10b was 2.4 μM. In vivo anticancer assay, 10b effectively inhibited MGC-803 xenograft tumor growth without causing significant loss of body weight. These sulfanilamide-1,2,3-triazole hybrids as potent tubulin polymerization inhibitors might be used as promising candidates for cancer therapy.
References
Mar 12, 2004·Nature·Raimond B G RavelliMarcel Knossow
Nov 9, 2005·Bioorganic & Medicinal Chemistry·L BouissaneG Guillaumet
Jan 22, 2008·Bioorganic & Medicinal Chemistry Letters·Ahmed KamalSurekha Zingde
Apr 9, 2008·Bioorganic & Medicinal Chemistry·Kristin OdloTrond Vidar Hansen
Mar 3, 2011·Journal of Medicinal Chemistry·Fabio PacchianoClaudiu T Supuran
Nov 11, 2011·European Journal of Medicinal Chemistry·Pardeep SinghA K Saxena
Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Sep 7, 2014·Bioorganic & Medicinal Chemistry·Ahmed KamalB Prasad
Dec 3, 2014·European Journal of Medicinal Chemistry·Małgorzata JeleńMaja Kocięba
Dec 19, 2015·Journal of Medicinal Chemistry·Thomas F GreeneMary J Meegan
Jan 23, 2016·Chemical Reviews·Vinod K TiwariXi Chen
Mar 15, 2016·European Journal of Medicinal Chemistry·Bruno M F GonçalvesMarta Cascante
Apr 30, 2016·Clinical Science·Stacy RobertsonSanjay Patel
Jun 10, 2016·Scientific Reports·Chia-Hsien WuJing-Ru Weng
Jul 18, 2016·Bioorganic & Medicinal Chemistry Letters·Dong-Jun FuYan-Bing Zhang
Aug 12, 2016·Angewandte Chemie·Josephin M HolsteinAndrea Rentmeister
Nov 3, 2016·Journal of Medicinal Chemistry·Pengfei ZhouYang Wang
Dec 23, 2016·Journal of Medicinal Chemistry·Christopher R CoxonCéline Cano
Jun 27, 2017·European Journal of Medicinal Chemistry·Sravanthi Devi GuggilapuNagendra Babu Bathini
Jul 18, 2017·Nature Communications·Akane Inoue-YamauchiEmily H Cheng
Sep 2, 2017·European Journal of Medicinal Chemistry·Giuseppe Felice MangiatordiOrazio Nicolotti
Sep 6, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dong-Jun FuYan-Bing Zhang
Oct 8, 2017·Scientific Reports·Dong-Jun FuHong-Min Liu
Oct 17, 2017·European Journal of Medicinal Chemistry·Muhamad MustafaOmar M Aly
Dec 22, 2017·European Journal of Medicinal Chemistry·Hong-Yan LinYong-Hua Yang
Jan 5, 2018·Oncotarget·Hiroyuki AraiTakako Eguchi Nakajima